1. Home
  2. Medical Research
  3. Ann Arbor, MI
  4. Sarc

Sarc

Sarc has an America's Best Score of 57 out of 100, based on its 2025 Form 990, below the 60-point bar to be ranked.

  • Ann Arbor, MI
  • Tax-exempt since 2004
  • EIN: 86-1087705
sarctrials.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
57OF 100 Not ranked Below the 60-point bar How this score is calculated

Organization summary

Sarc is a 501(c)(3) organization, classified under Medical Research (NTEE H90). Contributions are tax-deductible.

24 Frank Lloyd Wright Dr, Ann Arbor, MI 48105-9484

Among the 6 scored medical research organizations in Ann Arbor, Sarc holds 11.6 months of operating reserves (peer median 11 months), runs a typical yearly deficit of 13.6% (peers: surplus of 6.3%), and has cut spending 6.6% a year (peers: grown spending 3.5% a year).

In fiscal year 2025 it reported $2,089,223 in revenue and $2,868,975 in expenses, with contributions making up 89.5% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

SARC exists to provide a collaborative platform to make progress in the prevention, diagnosis, and treatment of sarcoma.

Main program · fiscal year 2025

  • The Sarcoma Alliance for Research Through Collaboration is a US-based non-profit sarcoma research cooperative solely dedicated to fostering progress in the prevention and treatment of sarcoma in order to improve patient outcomes and ultimately find a cure. SARC's unique ability to promote collaboration and unity among the sarcoma research community through scientific rigor, credibility and efficie… Read more

    The Sarcoma Alliance for Research Through Collaboration is a US-based non-profit sarcoma research cooperative solely dedicated to fostering progress in the prevention and treatment of sarcoma in order to improve patient outcomes and ultimately find a cure. SARC's unique ability to promote collaboration and unity among the sarcoma research community through scientific rigor, credibility and efficiency ensures that things get done. Collaborative partnerships and continued progress generate further investment in SARC's work for the good of the patients.

    $1,925,412 spent

Where each dollar went · fiscal year 2025

Of every dollar it spent, 67¢ went to programs, 30¢ to management and 3¢ to fundraising.

  • Programs $1,925,412
  • Management $858,165
  • Fundraising $85,398

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score57 / 100
DesignationNot ranked

Score breakdown

MeasureThis organizationPoints
Operating reserves11.6 mo; 11.4 mo in cash8.1 / 25
Financial balance (median margin)−13.6%6.3 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth−6.6% / yr4.2 / 15
Track record22 years8.8 / 10
Debt load6.5% of assets10 / 10
Total57.4 → 57
Spending on programs
Not scored; America's Best needs 65%+
67%Meets

Compared with Ann Arbor peers

MeasureThis organizationPeer median
Operating reserves11.6 mo11.0 mo
Typical margin−13.6%+6.3%
Spending growth−6.6% / yr+3.5% / yr
Debt load6.5%5.1%

Peers: the 6 Ann Arbor medical research organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$2,089,223Fiscal year 20252022: $3,308,15620222023: $3,705,57620232024: $2,780,00920242025: $2,089,2232025
Expenses$2,868,975Fiscal year 20252022: $3,523,58020222023: $3,466,62620232024: $3,522,27020242025: $2,868,9752025
Total assets$2,967,518Fiscal year 20252022: $4,435,16020222023: $4,647,61620232024: $3,914,88720242025: $2,967,5182025
Total liabilities$192,417Fiscal year 20252022: $460,08120222023: $377,81720232024: $321,88720242025: $192,4172025
Fiscal year ending December 2025
Revenue$2,089,223
Expenses$2,868,975
Net income−$779,752
Net assets$2,775,101

Notable sources of revenue

Percent of total revenue
Contributions$1,870,867
Program services$49,325
Investment income$167,556
Other (net)$1,475

Assets / debt

Total assets$2,967,518
Total liabilities$192,417
Net assets$2,775,101

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$2,780,009
Expenses$3,522,270
Net income−$742,261
Net assets$3,593,000

Notable sources of revenue

Percent of total revenue
Contributions$2,573,441
Program services$44,800
Investment income$154,206
Other (net)$7,562

Assets / debt

Total assets$3,914,887
Total liabilities$321,887
Net assets$3,593,000

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$3,705,576
Expenses$3,466,626
Net income$238,950
Net assets$4,269,799

Notable sources of revenue

Percent of total revenue
Contributions$3,603,220
Program services$9,200
Investment income$89,778
Other (net)$3,378

Assets / debt

Total assets$4,647,616
Total liabilities$377,817
Net assets$4,269,799

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$3,308,156
Expenses$3,523,580
Net income−$215,424
Net assets$3,975,079

Notable sources of revenue

Percent of total revenue
Contributions$3,311,272
Program services$0
Investment income$12,713
Other (net)−$15,829

Assets / debt

Total assets$4,435,160
Total liabilities$460,081
Net assets$3,975,079

Compensation

Officers and key employees$270,685
Share of expenses7.7%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?